Trial Profile
Effects of SGLT2 inhibitor (Suglat) on insulin sensitivity in patients with type 2 diabetes mellitus by the glucose clamp technique and the meal tolerance test
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2019
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 14 Jan 2019 Status changed from recruiting to completed.
- 23 Jul 2014 New trial record